Lung cancer is the leading cause of cancer-related deaths in the U.S. and most who are diagnosed with lung cancer do not survive five years.
In some cases, surgery can remove the primary tumor, but investigators from the University of Missouri School of Medicine and MU Health Care have identified a type of cell fusion between cancer cells and white blood cells called a tumor-macrophage fusion (TMF) where the size and number of the TMF cells may predict survival.
Dr. Jussuf Kaifi is an assistant professor of surgery at the MU School of Medicine and MU Health Care. He and his team of researchers studied non-small cell lung cancer (NSCLC) patients over three years and compared them to chronic, long-term smokers without lung cancer and healthy non-smokers without any known cancer.
He joins Dr. Roizen this episode to talk about this research and its findings.
Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor
How Your Diet Affects Your Risk for Cancer